Download PDF
Nuklearmedizin
DOI: 10.1055/a-1824-1280
Correction

Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy – A German position paper from Surgery and Nuclear Medicine

Individualisierte Behandlung von differenziertem Schilddrüsenkrebs: DerWert der Operation in Kombination mit Radiojodbildgebung und -therapie – Ein deutsches Positionspapier aus der Chirurgie und Nuklearmedizin
Matthias Schmidt
1   Department of Nuclear Medicine, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany
12   Thyroid Committee, German Society of Nuclear Medicine (DGN e. V.)
13   Guideline Committee, German Society of Nuclear Medicine (DGN e. V.)
,
Peter Bartenstein
2   Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
13   Guideline Committee, German Society of Nuclear Medicine (DGN e. V.)
,
Jan Bucerius
3   Department of Nuclear Medicine, University Medical Center Göttingen, Göttingen, Germany
,
Markus Dietlein
1   Department of Nuclear Medicine, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany
13   Guideline Committee, German Society of Nuclear Medicine (DGN e. V.)
,
Alexander Drzezga
1   Department of Nuclear Medicine, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany
,
Ken Herrmann
4   Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen and German Cancer Consortium (DKTK), Essen, Germany
,
Constantin Lapa
5   Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany
11   Member of the Board, German Society of Nuclear Medicine (DGN e. V.)
,
Kerstin Lorenz
6   Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University of Halle Wittenberg, Faculty of Medicine, Halle, Germany
14   Member of the surgical working group for endocrinology (CAEK) of the German society for general and visceral surgery (DGAV)
,
Thomas J. Musholt
7   Section of Endocrine Surgery, Department of General, Visceral and Transplantation Surgery, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany
14   Member of the surgical working group for endocrinology (CAEK) of the German society for general and visceral surgery (DGAV)
,
James Nagarajah
8   Department of Medical Imaging, Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherland
12   Thyroid Committee, German Society of Nuclear Medicine (DGN e. V.)
13   Guideline Committee, German Society of Nuclear Medicine (DGN e. V.)
,
Christoph Reiners
9   Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
,
Carsten O. Sahlmann
3   Department of Nuclear Medicine, University Medical Center Göttingen, Göttingen, Germany
12   Thyroid Committee, German Society of Nuclear Medicine (DGN e. V.)
,
Michael C. Kreissl
10   Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, Otto von Guericke University, Magdeburg, Germany
12   Thyroid Committee, German Society of Nuclear Medicine (DGN e. V.)
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Correction to:

Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy – A German position paper from Surgery and Nuclear MedicineNuklearmedizin 2022; 61(02): 87-96
DOI: 10.1055/a-1783-8154

Correction

Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy

Schmidt M, Bartenstein P, Bucerius J et al.

Nuklearmedizin 2022; 61(02): 87–96

10.1055/a-1783-8154

published online: 2022-03-17

In the above-mentioned article the Conflict of Interests and Reference [43] have been corrected.

Correct:

Michael C Kreißl: Bayer Healthcare: advisory board, event sponsoring; Eisai: advisory board, event sponsoring, talks; Exelixis: advisory bord, talk; GE Healthcare: talks, event sponsoring, research funding; Ipsen: talks, event sponsoring, travel funding, advisory bord; Takeda: talks; SanofiGenzyme: talks, travel, research funding; Siemens: event sponsoring; Curium: event sponsoring

[43] Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61 775 patients. Ann Surg. 2014 Oct; 260(4): 601-605; discussion 605-607. doi: 10.1097/SLA.0000000000000925. PMID: 25203876; PMCID: PMC4532384



Publication History

Article published online:
27 April 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany